An Overview of Epigenetics in Nursing

Nursing Clinics of North America

Volumn 48, Issue 4, 2013, Pages 649-659

  Clark, Ashley Erin ^a   Adamian, Maria ^b   Taylor, Jacquelyn Y ^a  

^a YALE UNIVERSITY   (United States)

^b SETON HALL UNIVERSITY   (United States)

Author keywords

Cancer; Epigenetics; Fetal; Metabolic syndrome; Nursing

Indexed keywords

EPIGENETICS; FETAL; GENETIC EPIGENESIS; HUMAN; MEDICAL GENETICS; METABOLIC SYNDROME X; NEOPLASM; NURSE ATTITUDE; NURSING; NURSING EDUCATION; NURSING PRACTICE; NURSING PROCESS; ORGANIZATION AND MANAGEMENT; REVIEW;

CANCER; EPIGENETICS; FETAL; METABOLIC SYNDROME; NURSING;

EDUCATION, NURSING; EPIGENESIS, GENETIC; GENETICS, MEDICAL; HUMANS; NURSE'S PRACTICE PATTERNS; NURSE'S ROLE; NURSING PROCESS;

EID: 84888364963     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2013.08.004     Document Type: Review

References (68)

1. Human genome project information: medicine and the new genetics [Internet]. 2011. Available at: Accessed December 29, 2012. http://www.ornl.gov/sci/techresources/Human_Genome/medicine/medicine.shtml.
2. Calzone K.A., Cashion A., Feetham S., et al. Nurses transforming health care using genetics and genomics. Nurs Outlook 2010, 58(1):26-35.
3. Baumgartel K., Zelazny J., Timcheck T., et al. Molecular genomic research designs. Annu Rev Nurs Res 2011, 29:1-26.
4. Dwivedi R.S., Herman J.G., McCaffrey T.A., et al. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 2011, 79(1):23-32.
5. Fire A., Xu S., Montgomery M.K., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391(6669):806-811.
6. Bjornsson H.T., Fallin M.D., Feinberg A.P. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004, 20(8):350-358.
7. Loescher L.J., Merkle C.J. The interface of genomic technologies and nursing. JNurs Scholarsh 2005, 37(2):111-119.
8. Dahlen H.G., Kennedy H.P., Anderson C.M., et al. The EPIIC hypothesis: intrapartum effects on the neonatal epigenome and consequent health outcomes. Med Hypotheses 2013, 80(5):656-662.
9. Hyde M.J., Mostyn A., Modi N., et al. The health implications of birth by caesarean section. Biol Rev Camb Philos Soc 2012, 87(1):229-243.
10. Cardwell C.R., Stene L.C., Joner G., et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 2008, 51(5):726-735.
11. Cook M.B., Graubard B.I., Rubertone M.V., et al. Perinatal factors and the risk of testicular germ cell tumors. Int J Cancer 2008, 122(11):2600-2606.
12. Goldani H.A., Bettiol H., Barbieri M.A., et al. Cesarean delivery is associated with an increased risk of obesity in adulthood in a Brazilian birth cohort study. Am J Clin Nutr 2011, 93(6):1344-1347.
13. Hakansson S., Kallen K. Caesarean section increases the risk of hospital care in childhood for asthma and gastroenteritis. Clin Exp Allergy 2003, 33(6):757-764.
14. Joffe T.H., Simpson N.A. Cesarean section and risk of asthma. The role of intrapartum antibiotics: a missing piece?. JPediatr 2009, 154(1):154.
15. Maghzi A.H., Etemadifar M., Heshmat-Ghahdarijani K., et al. Cesarean delivery may increase the risk of multiple sclerosis. Mult Scler 2012, 18(4):468-471.
16. Pistiner M., Gold D.R., Abdulkerim H., et al. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy. JAllergy Clin Immunol 2008, 122(2):274-279.
17. Thavagnanam S., Fleming J., Bromley A., et al. Ameta-analysis of the association between caesarean section and childhood asthma. Clin Exp Allergy 2008, 38(4):629-633.
18. 12. PLoS One 2012, 7(3):e33290.
19. Huh S.Y., Rifas-Shiman S.L., Zera C.A., et al. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study. Arch Dis Child 2012, 97(7):610-616.
20. Watson R.E., McKim J.M., Cockerell G.L., et al. The value of DNA methylation analysis in basic, initial toxicity assessments. Toxicol Sci 2004, 79(1):178-188.
21. Arita A., Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009, 1(3):222-228.
22. Poirier L.A., Vlasova T.I. The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ Health Perspect 2002, 110(Suppl 5):793-795.
23. Baccarelli A., Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009, 21(2):243-251.
24. Takiguchi M., Achanzar W.E., Qu W., et al. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res 2003, 286(2):355-365.
25. Ballestar E., Esteller M. The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications. Prog Mol Subcell Biol 2005, 38:169-181.
26. Foster W.G., McMahon A., Rice D.C. Sperm chromatin structure is altered in cynomolgus monkeys with environmentally relevant blood lead levels. Toxicol Ind Health 1996, 12(5):723-735.
27. Song C., Kanthasamy A., Anantharam V., et al. Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol Pharmacol 2010, 77(4):621-632.
28. Lahiri D.K., Maloney B., Zawia N.H. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009, 14(11):992-1003.
29. Ren X., McHale C.M., Skibola C.F., et al. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 2011, 119(1):11-19.
30. Donkena K.V., Young C.Y., Tindall D.J. Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int 2010, 2010:302051.
31. Zawia N.H., Lahiri D.K., Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 2009, 46(9):1241-1249.
32. Preeclampsia [Internet]. 2011. Available at: Accessed December 29, 2012. http://www.mayoclinic.com/health/preeclampsia/DS00583.
33. Anderson C. Fetal origins of hypertension: placental insufficiency linking cause and effect 2007, Midwest Nursing Research Society, Omaha (NE).
34. Uthus E.O., Anderson C.M. Epigenetic patterns in placental programming of preeclampsia 2010, Western Institute of Nursing, Carefree (AZ).
35. Wright M.L., Anderson C.M., Uthus E.O., et al. Validation of DNA methylation patterns: potential biomarker for heritable risk of preeclampsia. West J Nurs Res 2012, 34(8):1074-1075.
36. Senti J., Thiele D.K., Anderson C.M. Maternal vitamin D status as a critical determinant in gestational diabetes. JObstet Gynecol Neonatal Nurs 2012, 41(3):328-338.
37. Taylor J.T., Kraja A.T., de las Fuentas L., et al. An overview of the genomics of metabolic syndrome. JNurs Scholarsh 2013, 45(1):52-59.
38. Clark A.E., Taylor J.Y., Morrison H., et al. Alternative methods for measuring obesity in African American women. Yale J Biol Med 2013, 86(1):29-39.
39. Corwin E.J. The concept of epigenetics and its role in the development of cardiovascular disease: commentary on "new and emerging theories of cardiovascular disease". Biol Res Nurs 2004, 6(1):11-16. [discussion: 21-3].
40. Wung S.F., Hickey K.T., Taylor J.Y., et al. Cardiovascular genomics. JNurs Scholarsh 2013, 45(1):60-68.
41. Genomics Resources Diseases Knowing obesity and genetics [Internet]. 2010. Available at: Accessed January 19, 2013. http://www.cdc.gov/genomics/resources/diseases/obesity/obesknow.htm.
42. Taylor J.Y., Maddox R., Wu C.Y. Genetic and environmental risks for high blood pressure among African American mothers and daughters. Biol Res Nurs 2009, 11(1):53-65.
43. Taylor J.Y., Caldwell C.H., Baser R.E., et al. Classification and correlates of eating disorders among blacks: findings from the national survey of American life. JHealth Care Poor Underserved 2013, 24(1):289-310.
44. Taylor J.Y., Caldwell C.H., Baser R.E., et al. Prevalence of eating disorders among Blacks in the National Survey of American Life. Int J Eat Disord 2007, 40(Suppl):S10-S14.
45. Rowen L., Ross S., Milner J.A. Obesity, cancer, and epigenetics. Bariatr Surg Pract Patient Care 2010, 5:275-283.
46. Poy M.N., Eliasson L., Krutzfeldt J., et al. Apancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432(7014):226-230.
47. Immunotherapy [Internet]. 2012. Available at: Accessed January 19, 2013. http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-what-is-immunotherapy.
48. Atanackovic D., Luetkens T., Kloth B., et al. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia. Am J Hematol 2011, 86(11):918-922.
49. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant registry. NEngl J Med 1999, 341(1):14-21.
50. Brown M. Nursing care of patients undergoing allogeneic stem cell transplantation. Nurs Stand 2010, 25(11):47-56. [quiz: 58].
51. Frikeche J., Clavert A., Delaunay J., et al. Impact of the hypomethylating agent 5-azacytidine on dendritic cells function. Exp Hematol 2011, 39(11):1056-1063.
52. Goodyear O., Agathanggelou A., Novitzky-Basso I., et al. Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Blood 2010, 116(11):1908-1918.
53. Jabbour E., Giralt S., Kantarjian H., et al. Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer 2009, 115(9):1899-1905.
54. Santos E.M., Edwards Q.T., Floria-Santos M., et al. Integration of genomics in cancer care. JNurs Scholarsh 2013, 45(1):43-51.
55. Das P.M., Singal R. DNA methylation and cancer. JClin Oncol 2004, 22(22):4632-4642.
56. Aiello-Laws L. Genetic cancer risk assessment. Semin Oncol Nurs 2011, 27(1):13-20.
57. Weitzel J.N., Blazer K.R., Macdonald D.J., et al. Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin 2011, 61:327-359.
58. AAPM facts and figures on pain [Internet]. 2013. Available at: Accessed January 19, 2013. http://www.painmed.org/patientcenter/facts_on_pain.aspx#incidence.
59. Starkweather A.R., Pair V.E. Decoding the role of epigenetics and genomics in pain management. Pain Manag Nurs 2011, 12:1-10.
60. Diabetes statistics: data from the 2011 national diabetes fact sheet [Internet]. 2013. Available at: Accessed February 13, 2013. http://www.diabetes.org/diabetes-basics/diabetes-statistics/.
61. American Heart Association Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
62. Cancer prevalence [Internet]. 2013. Available at: Accessed February 13, 2013. http://www.cancer.org/cancer/cancerbasics/cancer-prevalence.
63. Conley Y.P., Biesecker L.G., Gonsalves S., et al. Current and emerging technology approaches in genomics. JNurs Scholarsh 2013, 45(1):5-14.
64. Hill V.K., Ricketts C., Bieche I., et al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res 2011, 71(8):2988-2999.
65. Summer Genetics Institute [Internet]. 2011. Available at: Accessed February 20, 2013. http://www.ninr.nih.gov/Training/TrainingOpportunitiesIntramural/SummerGeneticsInstitute/.
66. Prows C.A., Hetteberg C., Hopkin R.J., et al. Development of a web-based genetics institute for a nursing audience. JContin Educ Nurs 2004, 35(5):223-231.
67. Genomic Nursing State of the Science Advisory Panel, Calzone K.A., Jenkins J., et al. Ablueprint for genomic nursing science. JNurs Scholarsh 2013, 45(1):96-104.
68. Jenkins J.F., Calzone K.A. Are nursing faculty ready to integrate genomic content into curricula?. Nurse Educ 2012, 37(1):25-29.